Charissa Millevert

MD, neurologist in training, PhD student at VIB-Uantwerp center for molecular neurology working on the genetics of epilepsy

[Hannah Stamberger @HannahStamberg1]

Almost ready for our bike ride to support #STXBP1 research and to create awareness for rare genetic epilepsies !!!

@SWeckhuysen @noorzonnekein @NoorSmal @C_Millevert

[EpiCARE @EpiCARE_ERN]

🥼🧠Do you know "Genetic and environmental modifiers associated with KCNQ2-related disorders" Research Project? Do not miss the opportunity to learn about it on Collaborative Genetic Research webpage!

https://t.co/2xFcBF3uZ7

#EpiCARE #EU4Health #HealthUnion #Research

[Nina Dirkx @DirkxNina]

Excited to share our latest work! Check out how we increased prime editing rates using an EF1-a driven AIO plasmid. Big shout out to Wout Weuring @bobbykoeleman for the amazing collaboration! @Weckhuysen_team @CMN_VIB
https://t.co/0dRETvLBLe

[Charissa Millevert @C_Millevert]

Have you always wanted to know everything about self-limited (familial) epilepsies? From the first suspicion through to genetic diagnosis and treatment. Read our new paper: https://t.co/bxbDHgYuEU. @SWeckhuysen @IlaeWeb

[Sarah Weckhuysen @SWeckhuysen]

Today the world hopefully colours purple. International Epilepsy Day is denouncing the stigma that still exist against people with epilepsy. Stronger together! @Weckhuysen_team @C_Millevert @HannahStamberg1 @MatjasDW @noorzonnekein @NoorSmal @mark_kaji @DirkxNina #EpilepsyDay

[EpiCARE @EpiCARE_ERN]

Another impressive presentation from @C_Millevert 🇧🇪, on longitudinal, in-vivo functional and molecular imaging to characterize neurodevelopment from infantile to adult age in mice 🐭

#epilepsy #DEE #Neurotwitter @AntwerpU

[Charissa Millevert @C_Millevert]

We also showed in vitro blockade of Kv7.2 channels by #amitriptyline, a potential targeted treatment for patients with KCNQ2 GoF variants.

[Charissa Millevert @C_Millevert]

Did you know persons with #KCNQ2 GoF variants typically have ID without neonatal seizures? Check out our latest paper addressing phenotypes and functional properties of KCNQ2 R144W/Q/G variants: https://t.co/HSpCKEZ3cz @SWeckhuysen

[Konrad Platzer @platzer_k]

Charissa cont. w/ project on pre-clinical imaging biomarker of NDD in mouse model of #KCNQ2. Hypothesis is that neuro abnormalities occur early before onset of sz & can be detected using funct. imaging techniques 🔬 #LEGOLAS @SWeckhuysen

[Konrad Platzer @platzer_k]

Charissa Millevert from @SWeckhuysen group w/ @bobbykoeleman on #KCNQ2 modifier study (genetic, environment) to better explain phenotypic variability. #KCNQ2 is frequent so lots of potential data out there. happy to contribute #Leipzig patients where we have consent... #LEGOLAS

[JMG @JMG_BMJ]

#KCNQ2 encephalopathy is a severe disorder of early onset seizures & developmental delay. For the first time Boets et al describe the adult phenotype to inform parents of affected children

https://t.co/69OhuvEW27

#GeneticEpilepsy @SWeckhuysen @Katrine92658231 @FiladelfiaGene1

[weckhuysen_team @Weckhuysen_team]

We are hiring! We are looking for a postdoc to join our team to work on Kv7-associated encephalopathies using iPSC-derived models. https://t.co/TXKq2C3y2y

[VIB Center for Molecular Neurology @CMN_VIB]

Happy International Day of Women and Girls in Science! Grateful to work with these amazing scientists. Let's celebrate with this beautiful throwback picture of last year and let's hope we can make another one soon. #WomenInScience #VIB

[Charissa Millevert @C_Millevert]

The COVID-19 pandemic continues to impact the psychosocial and somatic well-being of persons with epilepsy worldwide. Read our paper to learn more: https://t.co/EWl42nBZgv. #InternationalEpilepsyDay #epilepsy #COVID19 @Weckhuysen_team

[weckhuysen_team @Weckhuysen_team]

Interested in precision medicine in genetic epilepsy? Join us at the 4th international Dianalund conference on Epilepsy and learn where we are, and what is next! Tune in Thursday to hear @SWeckhuysen talk about KCNQ2-Encephalopathy.